Literature DB >> 20649734

Hepatitis B virus-induced liver fibrosis and cirrhosis: the value of liver and spleen volumetry with multi-detector spiral computed tomography.

Wei Xia Li1, Xiang Tian Zhao, Wei Min Chai, Nai Yi Zhu, Lian Jun DU, Wei Huang, Hua Wei Ling, Ke Min Chen, Qing Xie.   

Abstract

OBJECTIVE: To study the correlation of liver and spleen volume with the degree of liver fibrosis and cirrhosis induced by hepatitis B virus infection.
METHODS: 128 participants who had undergone liver and spleen volumetry were enrolled. The control group consisted of 41 participants who were potential living liver donors. The liver fibrosis group consisted of 63 histologically proved liver fibrosis patients who were further divided into two subgroups: 44 patients with slight liver fibrosis, and 19 patients with advanced liver fibrosis. The liver cirrhosis group consisted of 24 patients. The following parameters were determined by multi-detector spiral computed tomography (MSCT) examination: total liver volume (TLV), right liver lobe volume (RV), left lateral liver segment volume (LLV), left medial liver segment volume (LMV), caudate lobe volume (CV), and spleen volume (SV). The ratios of CV to TLV (C/T), RV to TLV (R/T), LLV to TLV (LL/T), LMV to TLV (LM/T), and SV to TLV (S/T) were calculated.
RESULTS: TLV, RV, LMV tended to decrease and SV, C/T, S/T tended to increase gradually with the increased degree of fibrosis. C/T >or= 3.34% and S/T >or= 47.36% were identified as the cut-off values of fibrosis >or=F3 (advanced liver fibrosis) and cirrhosis, respectively. Their sensitivities were 68.4% and 87.5% and their specificities were 59.1% and 89.5%, respectively.
CONCLUSION: Variations in liver and spleen volume correlated with the degree of liver fibrosis and cirrhosis and could be used in the non-invasive follow-up of the development of liver fibrosis.

Entities:  

Mesh:

Year:  2010        PMID: 20649734     DOI: 10.1111/j.1751-2980.2010.00441.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  14 in total

1.  Magnetic resonance-based total liver volume and magnetic resonance-diffusion weighted imaging for staging liver fibrosis in mini-pigs.

Authors:  Hang Li; Tian-Wu Chen; Xiao-Li Chen; Xiao-Ming Zhang; Zhen-Lin Li; Nan-Lin Zeng; Li Zhou; Li-Ying Wang; Hong-Jie Tang; Chun-Ping Li; Li Li; Xian-Yong Xie
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

2.  Is computed tomography volumetric assessment of the liver reliable in patients with cirrhosis?

Authors:  Claire Goumard; Fabiano Perdigao; Julien Cazejust; Stéphane Zalinski; Olivier Soubrane; Olivier Scatton
Journal:  HPB (Oxford)       Date:  2013-05-17       Impact factor: 3.647

3.  Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.

Authors:  Tomohide Yoneyama; Yoshihiko Fukukura; Kiyohisa Kamimura; Koji Takumi; Aya Umanodan; Shinichi Ueno; Masayuki Nakajo
Journal:  Eur Radiol       Date:  2013-12-20       Impact factor: 5.315

4.  Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection.

Authors:  Jae Seok Bae; Dong Ho Lee; Jeongin Yoo; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Haeryoung Kim; Kyung Bun Lee
Journal:  Eur Radiol       Date:  2020-10-07       Impact factor: 5.315

5.  Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Authors:  Kazuki Takeishi; Hirofumi Kawanaka; Shinji Itoh; Norifumi Harimoto; Toru Ikegami; Tomoharu Yoshizumi; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

6.  Changes in Liver Volume in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy.

Authors:  Julie A Fitzpatrick; Jin Un Kim; Jeremy F L Cobbold; Mark J W McPhail; Mary M E Crossey; Aluel A Bak-Bol; Ashraf Zaky; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2015-12-06

7.  CT-scan Based Liver and Spleen Volume Measurement as a Prognostic Indicator for Patients with Cirrhosis.

Authors:  Milan Patel; Mark Tann; Suthat Liangpunsakul
Journal:  Am J Med Sci       Date:  2020-11-02       Impact factor: 3.462

8.  Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance.

Authors:  Chung Seop Lee; Yong Jin Jung; Soon Sun Kim; Jae Youn Cheong; Ga Ram Lee; Han Gyeol Kim; Beom Hee Kim; Jung Wha Chung; Eun Sun Jang; Sook-Hyang Jeong; Kyung Ho Lee; Jin-Wook Kim
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

9.  Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease.

Authors:  Woo Kyoung Jeong
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

10.  Liver lobe volumes and the ratios of liver lobe volumes to spleen volume on magnetic resonance imaging for staging liver fibrosis in a minipig model.

Authors:  Hang Li; Tian-wu Chen; Xiao-ming Zhang; Zhen-lin Li; Jin-ling Zhang; Dan Wang; Ting Li; Jian-lin Wu; Xing Guo; Xiao-li Chen; Li Li; Xian-yong Xie; Zi-shu Zhang
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.